These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 870188

  • 1. Estradiol binding in ovariectomy-responsive and -nonresponsive rat mammary carcinoma.
    Diamond EJ, Giladi M, Khan S, Hollander VP.
    Cancer Res; 1977 Jun; 37(6):1852-6. PubMed ID: 870188
    [Abstract] [Full Text] [Related]

  • 2. Prolactin binding in ovariectomy-responsive and ovariectomy-nonresponsive rat mammary carcinoma.
    Powell BL, Diamond EJ, Koprak S, Hollander VP.
    Cancer Res; 1977 May; 37(5):1328-32. PubMed ID: 15719
    [Abstract] [Full Text] [Related]

  • 3. The conversion of an ovariectomy-nonresponsive to an ovariectomy-responsive mammary tumor strain.
    Diamond EJ, Koprak S, Shen SK, Hollander VP.
    Cancer Res; 1976 Jan; 36(1):77-80. PubMed ID: 1248010
    [Abstract] [Full Text] [Related]

  • 4. The biological significance of estradiol receptor binding to DNA.
    Khan S, Feldman M, Hollander VP.
    Cancer Res; 1980 Apr; 40(4):1050-3. PubMed ID: 7357535
    [Abstract] [Full Text] [Related]

  • 5. Use of chromatofocusing to distinguish estradiol receptor from ovarian-dependent and -independent rat mammary tumors.
    Coufalik AH, Feldman M, Platica M, Toth L, Dreiling D, Hollander VP.
    Cancer Res; 1983 Nov; 43(11):5235-9. PubMed ID: 6616460
    [Abstract] [Full Text] [Related]

  • 6. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
    Manni A, Rainieri J, Arafah BM, Finegan HM, Pearson OH.
    Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
    [Abstract] [Full Text] [Related]

  • 7. Prolactin and estrogen binding in transplantable hormone-dependent and autonomous rat mammary carcinoma.
    Costlow ME, Buschow RA, Richert NJ, McGuire WL.
    Cancer Res; 1975 Apr; 35(4):970-4. PubMed ID: 163700
    [Abstract] [Full Text] [Related]

  • 8. Estradiol and progersterone receptors in F1 (C3H X RIII) mice mammary tumors: effect of castration.
    Edery M, Drosdowsky MA.
    Biomedicine; 1980 May; 33(3):80-2. PubMed ID: 7448327
    [Abstract] [Full Text] [Related]

  • 9. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
    Manni A, Trujillo JE, Pearson OH.
    Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
    [Abstract] [Full Text] [Related]

  • 10. Hormone, serum, and methylxanthine interactions in the regulation of DNA synthesis in organ-cultured rat mammary tumors.
    Mayer RM, Diamond EJ, Hollander VP.
    J Natl Cancer Inst; 1980 Nov; 65(5):1033-8. PubMed ID: 6159497
    [Abstract] [Full Text] [Related]

  • 11. Prolactin binding to R3230AC mammary carcinoma and liver in hormone-treated and diabetic rats.
    Smith RD, Hilf R, Senior AE.
    Cancer Res; 1977 Feb; 37(2):595-8. PubMed ID: 188551
    [Abstract] [Full Text] [Related]

  • 12. Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.
    Moreno-Cuevas JE, Sirbasku DA.
    In Vitro Cell Dev Biol Anim; 2000 Feb; 36(7):410-27. PubMed ID: 11039493
    [Abstract] [Full Text] [Related]

  • 13. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Shafie SM, Hilf R.
    Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
    [Abstract] [Full Text] [Related]

  • 14. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115.
    Noguchi S, Kitamura Y, Uchida N, Yamaguchi K, Sato B, Matsumoto K.
    Cancer Res; 1984 Dec; 44(12 Pt 1):5644-9. PubMed ID: 6498825
    [Abstract] [Full Text] [Related]

  • 15. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM, Bambara RA, Zain S, Hilf R.
    Cancer Res; 1989 Mar 01; 49(5):1165-70. PubMed ID: 2492902
    [Abstract] [Full Text] [Related]

  • 16. Correlation between hormone binding and growth response of rat mammary tumor.
    Holdaway IM, Friesen HG.
    Cancer Res; 1976 May 01; 36(5):1562-7. PubMed ID: 817797
    [Abstract] [Full Text] [Related]

  • 17. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM, Roberts RR, Alejandro MA, Clark JH.
    Cancer Res; 1984 Apr 01; 44(4):1515-9. PubMed ID: 6704964
    [Abstract] [Full Text] [Related]

  • 18. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
    Sylvester PW, Aylsworth CF, Van Vugt DA, Meites J.
    Cancer Res; 1983 Nov 01; 43(11):5342-6. PubMed ID: 6413057
    [Abstract] [Full Text] [Related]

  • 19. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC, Parsons JA.
    Cancer Res; 1981 May 01; 41(5):1772-7. PubMed ID: 7214344
    [Abstract] [Full Text] [Related]

  • 20. Increased susceptibility of cytosol proteins to proteolytic digestion during regression of a hormone-dependent mammary tumor.
    Rouleau M, Gullino PM.
    Cancer Res; 1977 Mar 01; 37(3):670-7. PubMed ID: 837367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.